Collection of Outcomes Data for Pregnant Patients with Cancer
- Conditions
- Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm
- Interventions
- Other: Medical Chart Review
- Registration Number
- NCT00507572
- Lead Sponsor
- M.D. Anderson Cancer Center
- Brief Summary
This study collects treatment and outcomes information on pregnant patients who are or were pregnant with cancer. Gathering and storing health information on pregnant patients with cancer, may provide data for future research studies and improve patient care.
- Detailed Description
PRIMARY OBJECTIVES:
I. To collect, both prospectively and retrospectively, data on disease characterization, treatment and outcome for pregnant patients with malignancies seen at M. D. Anderson Cancer Center.
II. To organize clinical information in order to support multifaceted queries of patient characteristics, treatment, and pregnancy outcome data and to facilitate correlation of these characteristics with patient outcome.
III. To have a single data repository, kept on a secure platform, that will integrate clinical information and research findings and serve as a secure archive for future research.
OUTLINE:
Patients' medical records are reviewed prospectively and retrospectively.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 500
- All pregnant patients with cancer and patients known to have been pregnant with a diagnosis of cancer are eligible, regardless of their diagnosis or treatment plan
- Patients may receive prenatal care from any obstetrician, but a consult with Maternal Fetal Medicine is encouraged
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Observational (medical chart review) Medical Chart Review Patients' medical records are reviewed prospectively and retrospectively.
- Primary Outcome Measures
Name Time Method Creation of data repository for patient characteristics, treatment, and pregnancy outcome data Up to 15 years
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
M D Anderson Cancer Center
🇺🇸Houston, Texas, United States